标题
Bedaquiline
作者
关键词
-
出版物
ANNALS OF PHARMACOTHERAPY
Volume 48, Issue 1, Pages 107-115
出版商
SAGE Publications
发表日期
2014-01-22
DOI
10.1177/1060028013504087
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Randomized Dose-Ranging Study of the 14-Day Early Bactericidal Activity of Bedaquiline (TMC207) in Patients with Sputum Microscopy Smear-Positive Pulmonary Tuberculosis
- (2013) Andreas H. Diacon et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Model-Based Estimates of the Effects of Efavirenz on Bedaquiline Pharmacokinetics and Suggested Dose Adjustments for Patients Coinfected with HIV and Tuberculosis
- (2013) Elin M. Svensson et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Approval of Novel TB Drug Celebrated--With Restraint
- (2013) J. Cohen SCIENCE
- Randomized Pilot Trial of Eight Weeks of Bedaquiline (TMC207) Treatment for Multidrug-Resistant Tuberculosis: Long-Term Outcome, Tolerability, and Effect on Emergence of Drug Resistance
- (2012) A. H. Diacon et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Tuberculosis: cost of illness in Germany
- (2012) Roland Diel et al. EUROPEAN RESPIRATORY JOURNAL
- Cost of tuberculosis in the era of multidrug resistance: will it become unaffordable?
- (2012) Robert Loddenkemper et al. EUROPEAN RESPIRATORY JOURNAL
- 14-day bactericidal activity of PA-824, bedaquiline, pyrazinamide, and moxifloxacin combinations: a randomised trial
- (2012) Andreas H Diacon et al. LANCET
- Pharmacokinetics and Pharmacodynamics of TMC207 and ItsN-Desmethyl Metabolite in a Murine Model of Tuberculosis
- (2011) Marie-Claude Rouan et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Safety, Tolerability, and Pharmacokinetic Interactions of the Antituberculous Agent TMC207 (Bedaquiline) With Efavirenz in Healthy Volunteers
- (2011) Kelly E. Dooley et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Treatment Outcomes among Patients with Extensively Drug‐Resistant Tuberculosis: Systematic Review and Meta‐Analysis
- (2010) Karen R. Jacobson et al. CLINICAL INFECTIOUS DISEASES
- New drugs and regimens for treatment of TB
- (2010) Eric Leibert et al. Expert Review of Anti-Infective Therapy
- TMC207: the first compound of a new class of potent anti-tuberculosis drugs
- (2010) Alberto Matteelli et al. Future Microbiology
- Bactericidal activity of the diarylquinoline TMC207 against Mycobacterium tuberculosis outside and within cells
- (2010) Jasvir Dhillon et al. TUBERCULOSIS
- Sterilizing Activity of R207910 (TMC207)-containing Regimens in the Murine Model of Tuberculosis
- (2009) Murad Ibrahim et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Epidemiology and clinical management of XDR-TB: a systematic review by TBNET
- (2009) G. Sotgiu et al. EUROPEAN RESPIRATORY JOURNAL
- The Diarylquinoline TMC207 for Multidrug-Resistant Tuberculosis
- (2009) Andreas H. Diacon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Early Bactericidal Activity and Pharmacokinetics of the Diarylquinoline TMC207 in Treatment of Pulmonary Tuberculosis
- (2008) R. Rustomjee et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now